Add Yahoo as a preferred source to see more of our stories on Google. On Saturday morning, a major rockfall occurred on the North Face of the Eiger, covering the Swiss valley in a cloud of dust. A ...

The following is a script from "Taking on the Eiger" which aired on Nov. 29, 2015. Anderson Cooper is the correspondent. Tom Anderson, producer. The Eiger -- in the Swiss Alps -- is one of the most ...

For months now, the oxygen seemed to be dwindling on Eiger’s COVID ambitions, especially after the FDA declined to grant emergency use authorization for the company’s treatment in October 2022. And ...

Eiger BioPharmaceuticals, Inc. EIGR announced that it has completed rolling submission of a new drug application (“NDA”) to the FDA for its pipeline candidate, lonafarnib. The NDA seeks approval for ...

December 2022 was one of those months for Eiger to prove the old saying what doesn't kill you, makes you stronger. Its executive shake-up is hard to ignore. New England Journal Of Medicine article put ...

Nicolas Hojac and Philipp Brugger have shattered a 21-year-old record, scaling the north faces of the Eiger, Mönch and Jungfrau in just 15 hours and 30 minutes. This is how they did it. Swiss pro ...

If a villain were about to kill James Bond at the top of a Swiss peak, 007 might make an incredible escape like this. And JT Holmes would be the stuntman to pull it off. The extreme sportsman has been ...

Getting your Trinity Audio player ready... Like many serious climbers, I’ve long dreamed of climbing the Eiger Nordwand, the north face of the Alps’ most notorious peak. Fortunately, I always wake up ...

Eiger BioPharmaceuticals is finally putting a pin in efforts to find a home for peginterferon lambda, a drug once tried in COVID-19 that has now failed in a study for chronic hepatitis delta. In a ...

The fearsome north wall of the Eiger which rears above the Swiss resort of Grindelwald has one of the most daunting reputations in the climbing world and many a drama has been played out on its face.

Eiger BioPharmaceuticals, Inc. EIGR announced that it has completed rolling submission of a new drug application (“NDA”) to the FDA for its pipeline candidate, lonafarnib. The NDA seeks approval for ...